Trials / Completed
CompletedNCT04035187
Itraconazole Oral Absorption
Prediction of Itraconazole Oral Absorption From In Vitro Dissolution
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- University of Maryland, Baltimore · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
For tablets to be absorbed, the drug must dissolve after being swallowed. Drugs with low solubility sometimes require the inert ingredients in tablets to help the drug dissolve after being swallowed. This study uses itraconazole as an example drug with low solubility. Itraconazole tablets with different inert ingredients and manufacturing will be administered to healthy volunteers to see if the different inert ingredients and manufacturing impact drug absorption.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fast itraconazole tablet | 100mg dose |
| DRUG | medium itraconazole tablet | 100mg dose |
| DRUG | slow itraconazole tablet | 100mg dose |
| DRUG | oral itraconazole solution | 100mg dose |
Timeline
- Start date
- 2020-02-10
- Primary completion
- 2022-05-21
- Completion
- 2022-05-21
- First posted
- 2019-07-29
- Last updated
- 2023-10-05
- Results posted
- 2023-10-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04035187. Inclusion in this directory is not an endorsement.